Segment 1 — The Cold Open

Segment 2 — The Old Way (Reasoning By Analogy)

Radial keratotomy, introduced in the 1970s and refined through the 1980s, treated myopia by placing a set number of radial incisions that allowed the cornea to flatten under intraocular pressure. The technique copied the logic of earlier manual eye surgery: a skilled hand guided a sharp instrument whose geometry had been perfected over decades. Diamond blades were the accepted standard because they held an edge longer than steel and produced cleaner cuts than any alternative then available. Each blade cost hundreds of dollars, required sterilization between cases, and still risked irregular depth that could induce astigmatism or glare. Operating rooms therefore treated the blade as a high-value consumable whose price was accepted as an unavoidable part of the procedure. No one questioned the underlying assumption that tissue removal had to occur through mechanical slicing rather than direct molecular bond breaking. That assumption locked the cost structure around the price of diamonds, the time needed for manual marking, and the risk margin built into every case. As a result, refractive procedures remained the province of specialized surgeons working in high-overhead settings where the blade itself represented only one slice of a much larger total expense. Surgeons trained for years to judge incision depth by feel and visual feedback, accepting variability that later became measurable against laser precision. The entire workflow therefore carried forward the economics of hand-crafted optics and single-use precious tools rather than asking what minimum energy input the cornea actually required.

Segment 3 — The First-Principles Move

The excimer approach began by asking what physical process could remove corneal collagen without mechanical contact or thermal damage. Researchers identified that 193-nanometer photons from an argon-fluoride laser could break carbon-nitrogen bonds in the tissue, ejecting fragments in a photochemical plume while leaving adjacent cells intact. Once that mechanism was established, the engineering task became delivering controlled pulses whose energy density sat just above the ablation threshold. Early systems required large, water-cooled lasers and complex beam-delivery optics, but the core physics—photon energy matching molecular bond strength—remained unchanged. Over successive generations, manufacturers replaced custom gas-handling assemblies with standardized modules whose commodity price fell as semiconductor lithography adopted the same wavelength. The magic-wand estimate for the materials consumed per eye therefore centers on a few liters of argon-fluoride gas mixture plus the electricity for a few hundred pulses; at current industrial gas prices those inputs total roughly twenty to forty dollars once the laser is already installed. The older blade-based Idiot Index was high because the finished procedure price incorporated hundreds of dollars in single-use diamond tooling plus the labor of manual alignment. Each redesign step that reduced optical-component count or lengthened gas-fill lifetime directly lowered that ratio by attacking the manufactured sub-systems rather than the raw photons or the corneal tissue itself. Trade-offs included the need for precise eye-tracking to keep the beam registered during the few seconds of ablation and the requirement that the corneal flap be created mechanically or with a femtosecond laser before the excimer step, both of which remain separate cost centers. One concrete consolidation was the move from discrete high-voltage power supplies and separate cooling loops to integrated solid-state drivers that reused waste heat within the gas recirculation path, cutting both mass and maintenance hours. Another was the standardization of the beam-delivery arm from custom-machined titanium mounts to cast aluminum assemblies whose tolerances could be held by the same CNC processes used for industrial scanners. A third move lengthened the interval between gas refills by improving the purity of the recirculation filters, so the same fill now supports several hundred more procedures before the fluoride concentration drops below the ablation threshold. Each of these changes addressed a specific manufactured intermediary rather than the fundamental photon-tissue interaction, which had already reached its physical limit once the 193-nanometer wavelength was chosen. The objection that biological variability still demands surgeon judgment is valid and explains why the remaining high-cost elements sit outside the ablation step itself.

Segment 4 — The Result & The Limits

Once excimer sources became standardized, the per-procedure hardware and energy cost settled in the range of tens of dollars for high-volume centers, a clear reduction from the hundreds previously spent on blades and setup. The new Idiot Index for the light-delivery portion itself is now low because the dominant remaining expenses sit in the flap-creation step, regulatory compliance, and clinic overhead rather than in the ablation materials. Limits persist around the initial capital cost of the laser platform, the need for a sterile field, and the biological variability of individual corneas that still requires surgeon oversight. The photochemical process itself has reached close to its physical floor; further gains would require commoditizing the entire delivery system or shifting flap creation to the same non-contact method. Reported outcomes show that the precision of depth control improved from roughly fifty-micrometer variability with blades to single-micrometer steps with the laser, yet the capital recovery and regulatory overhead still dominate the overall procedure price.

Segment 5 — The Lesson

A corneal surface whose shape is adjusted by counting photons instead of counting blade strokes shows that the cost driver often hides inside the assumed method of material removal. The same principle applies whenever a consumable tool can be replaced by a tunable energy source whose price scales with usage rather than with each individual part. Which other manual tissue-shaping procedures still carry high Idiot Indexes simply because no one has yet matched the photon energy to the molecular bond?

💬 Reply to this email — Patrick reads every one.

Share: X · LinkedIn · WhatsApp

Forwarded this email? Subscribe here — it's free.